Choroideremia Gene Therapy Clinical Trial
NCT02553135
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Choroideremia
Interventions
BIOLOGICAL:
Injection of AAV2-REP1 (10e11 vg)
Sponsor
Byron Lam